From the digestive system: more than 1% - dyspepsia, incl. nausea, vomiting, abdominal pain, constipation, flatulence, diarrhea; 0.1-1% - transient increase in the activity of "liver" transaminases, hyperbilirubinemia, eructation, esophagitis, gastroduodenal ulcer, bleeding from the gastrointestinal tract (including latent), stomatitis; less than 0.1% - perforation of the gastrointestinal tract, colitis, hepatitis, gastritis.
On the part of the hematopoiesis system: more than 1% - anemia; 0.1-1% change in the blood formula, incl. leukopenia, thrombocytopenia.
From the skin: more than 1% - itching, skin rash; 0,1-1% - urticaria; less than 0.1% - photosensitivity, bullous eruptions, erythema multiforme, incl. Stevens-Johnson syndrome, toxic epidermal necrolysis.
From the respiratory system: less than 0.1% - bronchospasm.
From the central nervous system (CNS): more than 1% - dizziness, headache; 0,1-1% - vertigo, tinnitus, drowsiness; less than 0.1% - confusion, disorientation, emotional lability.
From the side of the cardiovascular system (SSS): more than 1% - peripheral edema; 0.1-1% - increase in blood pressure (BP), palpitation, "tides" of blood to the skin of the face.
From the urinary system: 0.1-1% - hypercreatininaemia and / or elevated urea in the blood serum; less than 0.1% - acute renalfailure; communication with the reception of Myloxicam is not established - interstitial nephritis, albuminuria, hematuria.
From the sense organs: less than 0.1% - conjunctivitis, visual impairment, incl. blurred vision.
Allergic reactions: less than 0.1% - angioedema, anaphylactic / anaphylactoid reactions.
Local Reactions: more than 1% - puffiness at the injection site; less than 1% - painful sensations at the injection site.